AHA last week asked the Department of Health and Human Services to ensure hospitals quickly receive the funding to which they are entitled under last week鈥檚 Supreme Court decision in 黑料正能量 Association v. Becerra, without penalizing the rest of the hospital field. The court unanimously held that the prior Administration acted unlawfully when it severely reduced Medicare reimbursement rates for outpatient drugs provided by hospitals in the 340B program, but did not determine a remedy for the unlawful payment cuts. Instead, it remanded the case to the lower courts to address the proper remedy. 
 
鈥淕iven the vital role that 340B hospitals play in serving vulnerable communities, they should be repaid the funds that have been withheld from them without delay,鈥 . 鈥淭hey also should be paid for all of the years (2018-2022) in which the Centers for Medicare & Medicaid Services (CMS) illegally cut reimbursement rates. We are concerned, however, that despite the Supreme Court鈥檚 conclusive decision, resolution of these issues could be bogged down in needless litigation, and that hospitals will not be appropriately compensated at a time when they are weathering significant financial challenges on many fronts.鈥 
 
Among other concerns, AHA urged HHS not to apply budget neutrality when determining the appropriate remedy. 
 
鈥淎s you know, that position would mean that some hospitals will be forced to pay back money spent years ago 鈥 including during the COVID-19 pandemic 鈥 because the federal government made a legal error,鈥 the letter says. 鈥淗ospitals should not have to pay for the agency鈥檚 mistakes. Instead, this Administration should take the sensible (and legally correct) position that budget neutrality is not required when a court 鈥 here, all nine Justices of the Supreme Court 鈥 concludes the agency violated the law.鈥 
 

 

Related News Articles

Headline
A U.S. District Court for the District of Columbia judge June 27 ruled against Johnson & Johnson and sided with the Department of Health and Human Services鈥
Headline
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater鈥
Chairperson's File
Public
Advocacy is such an important part of what we do as hospitals and health systems 鈥 and what the AHA does on behalf of our field 鈥 to help ensure that we get鈥
Headline
The AHA June 4 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee in defense of the state鈥檚 340B contract pharmacy law鈥
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B 鈥渞ebate鈥
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state鈥檚 340B contract pharmacy law鈥